This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Print Page   |   Contact Us   |   Sign In   |   Register
Community Search
News & Press: Executive Director's Blogs

CASSS is Grateful for our Members

Thursday, March 19, 2020   (1 Comments)
Posted by: Stephanie Flores
Share |

March is Member Month

Today I'm writing this message from my temporary home office in my dining room. It's an extraordinary time - far different than anything I imagined as I introduced the "Member Month" theme last year. Perhaps it's that difference that has me a bit nostalgic - and even more appreciative of the work to which you, our members, have dedicated your careers.

The biotechnology landscape has evolved dramatically since CASSS was founded in the early 1980s. Many early leaders such as Gene Murano, Kathryn Zoon and Tony Lubiniecki are now regarded as pioneers, working together from their various perspectives in industry, regulatory and academia to tackle problems for which there were no known answers.  John Petricciani, MD, a former director of biologics at the FDA and CASSS Hancock Award winner said when accepting the award, “It was my privilege to have helped nurture – and sometimes nudge – the regulatory systems to accommodate to the many advances that have been made during the past 50 years. Real progress is made when industry and regulatory authorities tackle a problem together on the basis of sound scientific principles and hard data that support decision-making."

Associations are, by definition, groups of persons banded together for a common purpose.  CASSS' core purpose is to provide a forum for our members to come together to engage in critical discussions and share best practices to advance the field of biopharmaceutical development and regulation. That culture of dynamic dialogue and engagement between regulators and industry has contributed to significant advances in life-saving medicines and treatments.  Those relationships and the trust that has been built is being called upon now to address the unprecedented challenge presented by the COVID-19 pandemic. We're seeing today's leaders stepping up with innovative partnerships and accelerated research.

The CASSS staff and I are proud of the small part we play in facilitating the work that you do through the knowledge-sharing and networking our conferences provide. We continue to strive toward our vision of building a global community working to resolve scientific challenges in biopharmaceutical development.  Like you, we're also seeking ways this crisis can push us toward innovation. One is in thinking about ways we can bring people together beyond our face-to-face conferences, both now in crisis as well as beyond. We'd appreciate your thoughts on virtual conferences and communities. Please email me at sflores (at) - or leave a comment below.

On behalf of the Board of Directors and staff, I thank you, our members and stakeholders. We continue to work daily to advance the field of biopharmaceutical development and regulation. We truly appreciate that you have joined us in this journey.

Thank you,

Stephanie Flores
Executive Director


Eef Dirksen, Byondis B.V. says...
Posted Tuesday, March 24, 2020
Thanks Stephanie, well said. I'm still happy to have joined CASSS following my first attendance of the Mass Spec meeting years ago. I think the CASSS community is a very pleasant one and specifically stands out -to me at least- for its meetings that I've found to be perfect with regard to a) size (i.e. number of attendees) and b) openness (to the extent possible) of discussions: industrial colleagues share insights and problems they run into, which can be very helpful for all, including academic colleagues that often join in to help out with their knowledge and expertise to improve and expand the opportunities of ongoing analytical developments in the field. I was very much looking forward to attending and contributing to AT Europe 2020 in Lisboa earlier this month, but then the corona virus got in the way. Let's hope we get through this global crisis together so that we're able to convene in Portugal later this year after all. Take care and stay safe!

more Calendar

9/28/2020 » 10/1/2020
CE Pharm 2020

10/13/2020 » 10/15/2020
CMC Strategy Forum North America Fall 2020

Membership Software Powered by YourMembership  ::  Legal